Clinical Trials and Research

SOLA Japan to Accelerate Development of SOL-257 for ALS with AMED Grant

Through the AMED-supported program, SOLA Japan will serve as a central development hub in Japan...

AI can help imaging services do more with existing workforce and infrastructure: Ari Wood

Ari Wood, Acting Head of Imaging, Australia and New Zealand and Head of CT/AMI, Growth Region at Philips, discusses how AI-enabled MRI and CT technologies can address rising imaging demand, workforce constraints and regional access gaps across Australia and New Zealand....

CooperVision Unveils Six Contact Lens Innovations at New Global Vision Centre

The state-of-the-art facility is designed to create faster learning cycles and accelerate the path from idea to market-ready solution...

Engineering Cleaner Micro-Hole Meshes for More Consistent Inhalation Drug Delivery

The company manufactures mesh atomisers with laser-drilled holes as small as 2.0 microns, enabling device developers to engineer aerosol characteristics for specific inhalation applications...

Ferronova reports early MAGMAP results for nanoparticle-guided cancer lymph node mapping

The 62-patient multicentre trial is evaluating a nanoparticle-based platform designed to help identify sentinel lymph nodes in gastric and oesophageal cancer surgery....

Perosphere ClotChek Study Shows Rapid Detection of DOAC Anticoagulation

The information contained herein represents a summary of the peer-reviewed journal article published in Thrombosis and Haemostasis entitled "Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors"...

The Future of Alzheimer’s Diagnosis: From PET Imaging to Blood-Based Biomarkers

ALZpath’s proprietary p-tau217 antibody has been extensively studied in peer-reviewed research and is being integrated into automated in vitro diagnostic platforms ...

Sky Labs Unveils New Clinical Data for CART Blood Pressure Monitor at ESC 2026

The CART blood pressure monitor enables continuous BP tracking even in AF and HF patients ...

Fujirebio’s Lumipulse NfL, pTau 217 Assays Receive Health Canada Licences

These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions ...

Roche’s Columvi Added to Singapore’s Subsidised Drug Lists for DLBCL

This underscores an urgent need for a broader range of novel and efficacious treatment options...